CCL2 promotes proliferation, migration and angiogenesis through the MAPK/ERK1/2/MMP9, PI3K/AKT, Wnt/β‑catenin signaling pathways in HUVECsZhonghua Peng(Guangdong Medical College), Bo Wei(Guangdong Medical College)Experimental and Therapeutic MedicineDecember 27, 202210.3892/etm.2022.11776Cited by 25SaveCiteExport RISWatch citationsRelated PapersExploration of anti‑osteosarcoma activity of asiatic acid based on network pharmacology and<i>in vitro</i>experiments|Oncology Reports|2023|5